Company
Since 1909, Grifols has worked to improve the health and well-being of people around the world.
Read more
Every action we take is motivated by our mission to improve people's lives.
Our unique and remarkable history combines scientific expertise with a desire to serve patients and society.
We develop, produce and market innovative medicines, solutions and services in more than 110 countries.
Innovation
Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.
We apply our growing knowledge of plasma to change healthcare.
Our treatments are enhancing people’s well-being and quality of life.
We’re drawing on a broad scientific base to continue innovating.
Sustainability
Grifols' longstanding commitment to people and the planet entails helping society on all fronts.
2022 Sustainability Report: a detailed overview of our sustainability strategy, actions and progress
Read
Patients drive the work we do every day. We support patients and patient associations.
Learn more
As mindful stewards of the environment we are resolved to fight climate change.
Investors
Here you can read our Q2 2023 financial results
Read results
Please click here to listen to the webcast of our Q2 2023 financial results
Listen to the webcast
The 2022 Integrated and Sustainability Annual Report is now available
Careers
People are at the heart of our business. We are committed to continued investment in training and development.
Media
Latest news about the company and contact information for journalists and communication professionals.
Contact
Current articles of association that include the latest amendments approved by the Ordinary General Shareholders Meeting on 16 June 2023 and registered with the Commercial Registry of Barcelona on 16 August 2023.
Articles of Association Grifols S.A
